1Arndt SO,Vogt AB and Markovic-Plese S,et al. Functional HLADM on the surface of B cell and immature dendritic cells. The EMBO Journal,2000,19(6) :1241-1251.
2Kelly AP, Monaco JJ and Cho SG, et al. A new human HLA class II -related locus, DM. Nature, 1991,353 (6344) :571-573.
3Denzin LK, Fallas JL, Prendes M, et al. Right place, right time, right peptide:DO keeps DM focused. Immunol Reviews 2005,207 ( 1 ) : 279-292.
4Mosyak L,Zaller DM, Wiley DC. The structure of HLA-DM,the peptide exchange catalyst that loads antigen on to class II MHC molecules during antigen presentation. Immunity, 1998,9 (1) :377- 383.
5Sadegh-Nasseri S, Chen M, Narayan K, et al. The convergent roles of tapasin and HLA-DM in antigen presentation. Trends in Immunology,2008,29 (3) : 141-147.
7Deshaies F, Diallo DA, Fortin JS, et al. Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DOβ. Immunology,2008,127 (3) :408 -417.
8Deshaies F, Brunet A, Diallo DA, et al. A point mutation in the groove of HLA-DO allows egress from the endoplasmie retieulum independent of HLA-DM. PNAS,2005,102 (18) :6443-6448.
9Hake SB,Tobin HM, Steimle V, et al. Comparison of the transcriptional regulation of classical and non-classical MHC class II genes. Eur J Immunol,2003,33(9) : 2361-2371.
10Van Ham M, Van Lith M, Griekspoor A, et al. What to do with HLA-DO? lmmunogenetics ,2000,51 (10) :765-770.
